Earlier in February, the company had announced the bonus issue while releasing the October-December quarter results for FY26. The board approved the issue of bonus shares in the ratio of 3:1, which means three fully paid equity shares of face value of Rs 2 each for every fully paid equity share of face value of Rs 2 each held by the shareholders.
Later, on March 10, the company announced that the record date has been set for March 20 (Friday).
What does this mean for stakeholders?
If a shareholder owns one share of the company worth Rs 100, the 3:1 bonus issue will convert it into four shares worth around Rs 25 each. The total value of the holding remains unchanged at Rs. Once the stock starts trading past the bonus, the price falls sharply, but this simply reflects a correction after the corporate action.
Only shareholders who held stock on the record date are eligible to receive bonus shares. Bonus issues consist of bonus shares distributed by a company from its reserves and are often seen as a sign of strong financial health and growth prospects.
While the issue of bonus shares increases the total number of shares outstanding, it does not change the market capitalization of the company. However, it can improve liquidity and liquidity, allowing more investors to invest in the stock.
Metropolis Healthcare Share Price:
Shares of Metropolis Healthcare have risen about 4% over the past five days, but are down about 7% over the past month. The small-cap stock has fallen nearly 11% over the past six months, and about 5% so far in 2026. The stock currently has a P/E ratio of around 56, and a market capitalization of Rs 9,382 crore, according to NSE data.
(Disclaimer: The suggestions, recommendations, views and opinions given by the experts are their own. They do not represent the views of The Economic Times)
